Bio-Rad Laboratories (BIO.B) Competitors

Keysight Technologies (NYSE:KEYS) and Bio-Rad Laboratories (NYSE:BIO.B) are both measuring and control equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Which has more risk & volatility, KEYS or BIO.B?

Keysight Technologies has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Is KEYS or BIO.B more profitable?

Bio-Rad Laboratories has a net margin of 12.50% compared to Keysight Technologies' net margin of 10.36%. Keysight Technologies' return on equity of 19.53% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Keysight Technologies	10.36%	19.53%	10.51%
Bio-Rad Laboratories	12.50%	4.01%	2.82%

Do analysts prefer KEYS or BIO.B?

Keysight Technologies presently has a consensus target price of $187.38, indicating a potential upside of 8.74%. Given Keysight Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe Keysight Technologies is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Keysight Technologies	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Bio-Rad Laboratories	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has better earnings & valuation, KEYS or BIO.B?

Keysight Technologies has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Keysight Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Keysight Technologies	$4.98B	5.95	$614M	$3.14	54.88
Bio-Rad Laboratories	$2.57B	3.02	-$1.84B	$11.73	24.29

Do institutionals and insiders hold more shares of KEYS or BIO.B?

84.6% of Keysight Technologies shares are held by institutional investors. Comparatively, 0.0% of Bio-Rad Laboratories shares are held by institutional investors. 0.6% of Keysight Technologies shares are held by insiders. Comparatively, 28.4% of Bio-Rad Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the media prefer KEYS or BIO.B?

In the previous week, Keysight Technologies had 11 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 12 mentions for Keysight Technologies and 1 mentions for Bio-Rad Laboratories. Keysight Technologies' average media sentiment score of 1.06 beat Bio-Rad Laboratories' score of -1.14 indicating that Keysight Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Keysight Technologies	9 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Rad Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

Summary

Keysight Technologies beats Bio-Rad Laboratories on 13 of the 16 factors compared between the two stocks.